US Patent Issued to BEIJING TIDE PHARMACEUTICAL on Feb. 10 for "2, 4, 6-tri-substituted pyrimidine compound as ATR kinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,382, issued on Feb. 10, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing).

"2, 4, 6-tri-substituted pyrimidine compound as ATR kinase inhibitor" was invented by Yanping Zhao (Beijing), Hongjun Wang (Beijing), Bin Liu (Beijing), Yuanyuan Jiang (Beijing), Weiting Zhong (Beijing), Huifen Xu (Beijing), Honglei Zhang (Beijing), Chuangchuang Huang (Beijing), Nana Tian (Beijing), Jing Zhao (Beijing), Jing Li (Beijing), Weina Liu (Beijing), Liying Zhou (Beijing) and Yanan Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of general formula (A) can be used for treating ATR kinase-mediated diseases, for example, hyperplastic d...